摘要
目的:探讨新生儿呼吸窘迫综合征(NRDS)的呼吸机治疗策略.方法:观察本院综合重症监护病房的20例NRDS均需呼吸机治疗的患儿随机分为Y、N两组,每组10人.Y组在呼吸机治疗期间,根据临床反应、血气分析结果、呼吸机参数(以降低潮气量为主)相互关系而调节,最终达pH(7.35~7.45),PaCO2(40~70)mmHg,PaO2(50~70)mmHg的允许性高碳酸血症.而N组患儿以同样的方式,维持pH 7.35~7.45,PaCO2(35~45)mmHg,PaO2(50~70)mmHg的非允许性高碳酸血症.用多功能心电监护仪持续监测心率、脉搏血氧饱和度(SpO2)并维持在85%~90%,每2h进行一次生命体征监测,入室即测动脉血气一次,随后每8 h监测一次动脉血气,呼吸机应用过程中每天床边胸片检查,病情有变化随时摄片.同时记录两组患儿FiO2、PIP、PEEP、Ti、MAP、血气分析值、呼吸机应用时间(相当于用氧时间)、住院天数.结果:两组呼吸机参数、平均气道压MAP和吸气压峰值PIP比较,P<0.05差别有显著性.血气检测结果两组比较PaCO2差别有显著性.Y组患儿采取允许性高碳酸血症(低潮气量)使PIP降低,同时缩短Ti,结果使MAP下降,PaCO2(48±6)mmHg,呈轻度升高,而PaO2(59±16)mmHg与N组相比较无显著性,pH值为7.31±0.04,在允许范围内,心率(HR)和平均动脉压(BP)与N组相比较无明显差别.两组并发症及疗效与N组比较,P<0.05.显示新生儿RDS呼吸机治疗时采用允许性高碳酸血症可有效缓解相关性肺损伤,降低病死率.结论:新生儿RDS呼吸机治疗时采用允许性高碳酸血症可有效缓解相关性肺损伤,降低死亡率.对NRDS后的呼吸机治疗具有临床意义.
Objective:To investigate the neonatal respiratory distress syndrome(NRDS) for the treatment of respiratory strategy.Methods: 20 NRDS,who were treated with ventilator in Intensive Care Unit,were assigned to the group Y and group N each 10 in the group Y permissive hypercapnia was induced according to clinical response,blood gas analysis,the ventilator's parameters until pH(7.35~7.45),PaCO2(40 ~70)mmHg,PaO2(50~70)mmHg at last.In the group N non-permissive hypercapnia was allowed to pH(7.35~7.45),PaCO2(35~45)mmHg,PaO2(50 ~70)mmHg.Heart rate and oxygen saturation(SaO2) were measured by multifunction ECG monitor and level of SaO2 was maintained at 85% to 90%.A vital signs,blood gas and chest X-ray were examined;and FiO2 peak inspiratory pressure(PIP),PEEP,Ti,MAP were recorded in two groups.Results:The level of MAP and PIP had difference between ventilator parameters and the average N airway pressure(P<0.05).There was a significant difference of PaCO2compared that with group N In group Y,decreased PIP and MAP,short Ti and less increased PaCO2 were found.No difference of PaO2(59±16),HR and BP compared with the N group.Conclusions: Treatment of permissive hypercapnia in NRDS with ventilator can release lung injury event and decrease the mortality of children with RDS in clinic.
出处
《青海医药杂志》
2007年第8期9-11,共3页
Qinghai Medical Journal